NBP233094FR

MAGE 1 Antibody (MA454), DyLight 680, Novus Biologicals™

Manufacturer: Novus Biologicals

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP233094FR-Each-of-1 In Stock ₹ 55,271.76

NBP233094FR - Each of 1

₹ 55,271.76

In Stock

Quantity

1

Base Price: ₹ 55,271.76

GST (18%): ₹ 9,948.917

Total Price: ₹ 65,220.677

Antigen

MAGE 1

Classification

Monoclonal

Conjugate

DyLight 680

Gene Alias

Antigen MZ2-E, Cancer/testis antigen 1.1, cancer/testis antigen family 1, member 1, CT1.1melanoma antigen family A 1, MAGE-1 antigen, MAGE1A, MAGE1melanoma antigen MAGE-1, melanoma antigen family A, 1 (directs expression of antigen MZ2-E), melanoma-associated antigen 1, melanoma-associated antigen MZ2-E, MGC9326

Host Species

Mouse

Molecular Weight of Antigen

44 kDa

Quantity

0.1 mL

Research Discipline

Apoptosis, Cancer, Melanoma Cell Markers, Tumor Suppressors

Gene ID (Entrez)

4100

Target Species

Human, Rat, Canine

Form

Purified

Applications

ELISA

Clone

MA454

Dilution

ELISA

Gene Symbols

MAGEA1

Immunogen

Recombinant full-length human MAGE 1 protein (Uniprot: P43355)

Purification Method

Protein A or G purified

Regulatory Status

RUO

Primary or Secondary

Primary

Test Specificity

Recognizes a protein of 42-46kDa, identified as MAGE-1. This monoclonal antibody does not cross-react with MAGE-2, -3, -4, -6 -9, -10, -or -12 protein. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8+ T lymphocyte clones (CTL). The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.

Content And Storage

Store at 4C in the dark.

Isotype

IgG1 κ

Related Products

Img

Novus Biologicals

NBP234754Z

--

Img

Novus Biologicals

NBP234786P

--

Img

Novus Biologicals

NBP234786H

--

Img

Novus Biologicals

NBP233150Z

--

Img

Novus Biologicals

NBP233148Z

--

Img

Novus Biologicals

NBP234753Y

--

Img

Novus Biologicals

NB252060

--

Img

Novus Biologicals

NBP234768X

--

Description

  • MAGE 1 Monoclonal specifically detects MAGE 1 in Human, Rat, Canine samples
  • It is validated for ELISA.

Compare Similar Items

Show Difference

Img

Novus Biologicals

NBP233094FR

--


Antigen:
MAGE 1

Classification:
Monoclonal

Conjugate:
DyLight 680

Gene Alias:
Antigen MZ2-E, Cancer/testis antigen 1.1, cancer/testis antigen family 1, member 1, CT1.1melanoma antigen family A 1, MAGE-1 antigen, MAGE1A, MAGE1melanoma antigen MAGE-1, melanoma antigen family A, 1 (directs expression of antigen MZ2-E), melanoma-associated antigen 1, melanoma-associated antigen MZ2-E, MGC9326

Host Species:
Mouse

Molecular Weight of Antigen:
44 kDa

Quantity:
0.1 mL

Research Discipline:
Apoptosis, Cancer, Melanoma Cell Markers, Tumor Suppressors

Gene ID (Entrez):
4100

Target Species:
Human, Rat, Canine

Form:
Purified

Applications:
ELISA

Clone:
MA454

Dilution:
ELISA

Gene Symbols:
MAGEA1

Immunogen:
Recombinant full-length human MAGE 1 protein (Uniprot: P43355)

Purification Method:
Protein A or G purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Test Specificity:
Recognizes a protein of 42-46kDa, identified as MAGE-1. This monoclonal antibody does not cross-react with MAGE-2, -3, -4, -6 -9, -10, -or -12 protein. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8+ T lymphocyte clones (CTL). The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.

Content And Storage:
Store at 4C in the dark.

Isotype:
IgG1 κ

Img

Novus Biologicals

NBP233094G

--


Antigen:
MAGE 1

Classification:
Monoclonal

Conjugate:
DyLight 488

Gene Alias:
Antigen MZ2-E, Cancer/testis antigen 1.1, cancer/testis antigen family 1, member 1, CT1.1melanoma antigen family A 1, MAGE-1 antigen, MAGE1A, MAGE1melanoma antigen MAGE-1, melanoma antigen family A, 1 (directs expression of antigen MZ2-E), melanoma-associated antigen 1, melanoma-associated antigen MZ2-E, MGC9326

Host Species:
Mouse

Molecular Weight of Antigen:
44 kDa

Quantity:
0.1 mL

Research Discipline:
Apoptosis, Cancer, Melanoma Cell Markers, Tumor Suppressors

Gene ID (Entrez):
4100

Target Species:
Human, Rat, Canine

Form:
Purified

Applications:
ELISA

Clone:
MA454

Dilution:
ELISA

Gene Symbols:
MAGEA1

Immunogen:
Recombinant full-length human MAGE 1 protein (Uniprot: P43355)

Purification Method:
Protein A or G purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Test Specificity:
Recognizes a protein of 42-46kDa, identified as MAGE-1. This monoclonal antibody does not cross-react with MAGE-2, -3, -4, -6 -9, -10, -or -12 protein. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8+ T lymphocyte clones (CTL). The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.

Content And Storage:
Store at 4C in the dark.

Isotype:
IgG1 κ

Img

Novus Biologicals

NBP233094R

--


Antigen:
MAGE 1

Classification:
Monoclonal

Conjugate:
DyLight 550

Gene Alias:
Antigen MZ2-E, Cancer/testis antigen 1.1, cancer/testis antigen family 1, member 1, CT1.1melanoma antigen family A 1, MAGE-1 antigen, MAGE1A, MAGE1melanoma antigen MAGE-1, melanoma antigen family A, 1 (directs expression of antigen MZ2-E), melanoma-associated antigen 1, melanoma-associated antigen MZ2-E, MGC9326

Host Species:
Mouse

Molecular Weight of Antigen:
44 kDa

Quantity:
0.1 mL

Research Discipline:
Apoptosis, Cancer, Melanoma Cell Markers, Tumor Suppressors

Gene ID (Entrez):
4100

Target Species:
Human, Rat, Canine

Form:
Purified

Applications:
ELISA

Clone:
MA454

Dilution:
ELISA

Gene Symbols:
MAGEA1

Immunogen:
Recombinant full-length human MAGE 1 protein (Uniprot: P43355)

Purification Method:
Protein A or G purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Test Specificity:
Recognizes a protein of 42-46kDa, identified as MAGE-1. This monoclonal antibody does not cross-react with MAGE-2, -3, -4, -6 -9, -10, -or -12 protein. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8+ T lymphocyte clones (CTL). The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.

Content And Storage:
Store at 4C in the dark.

Isotype:
IgG1 κ

Img

Novus Biologicals

NBP233094V

--


Antigen:
MAGE 1

Classification:
Monoclonal

Conjugate:
DyLight 405

Gene Alias:
Antigen MZ2-E, Cancer/testis antigen 1.1, cancer/testis antigen family 1, member 1, CT1.1melanoma antigen family A 1, MAGE-1 antigen, MAGE1A, MAGE1melanoma antigen MAGE-1, melanoma antigen family A, 1 (directs expression of antigen MZ2-E), melanoma-associated antigen 1, melanoma-associated antigen MZ2-E, MGC9326

Host Species:
Mouse

Molecular Weight of Antigen:
44 kDa

Quantity:
0.1 mL

Research Discipline:
Apoptosis, Cancer, Melanoma Cell Markers, Tumor Suppressors

Gene ID (Entrez):
4100

Target Species:
Human, Rat, Canine

Form:
Purified

Applications:
ELISA

Clone:
MA454

Dilution:
ELISA

Gene Symbols:
MAGEA1

Immunogen:
Recombinant full-length human MAGE 1 protein (Uniprot: P43355)

Purification Method:
Protein A or G purified

Regulatory Status:
RUO

Primary or Secondary:
Primary

Test Specificity:
Recognizes a protein of 42-46kDa, identified as MAGE-1. This monoclonal antibody does not cross-react with MAGE-2, -3, -4, -6 -9, -10, -or -12 protein. Human malignant neoplasms carry rejection antigens that are recognized by the patients' autologous, tumor directed and specific, cytolytic, CD8+ T lymphocyte clones (CTL). The MAGE family of genes codes an important group of antigens. It was identified that melanomas and primary glial brain tumors express common melanoma associated antigens (MAAs). Because MAGE-1 is expressed on a significant proportion of human neoplasms of various histological types (melanoma, brain tumors of glial origin, neuroblastoma, non-small cell lung cancer, breast, gastric, colorectal, ovarian, renal cell carcinomas) and not on normal tissues, the encoded antigen may serve as a marker of early detection and target for cancer immunotherapy.

Content And Storage:
Store at 4C in the dark.

Isotype:
IgG1 κ